%2C%20Inc./other/PharmaBlock_Sciences_Nanjing_Inc.-logo.png)
PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings
PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于注销部分募集资金专项账户的公告 | 2023-07-03 | Chinese | |
| 关于股东减持股份计划实施完成的公告 | 2023-07-02 | Chinese | |
| 关于不向下修正药石转债转股价格的公告 | 2023-06-30 | Chinese | |
| 关于公司高管辞职的公告 | 2023-06-30 | Chinese | |
| 关于签订募集资金三方监管协议的公告 | 2023-06-30 | Chinese | |
| 关于药石转债可能触发向下修正转股价格条件的提示性公告 | 2023-06-21 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 40020462 | 关于注销部分募集资金专项账户的公告 | 2023-07-03 | Chinese | ||
| 40020457 | 关于股东减持股份计划实施完成的公告 | 2023-07-02 | Chinese | ||
| 40020443 | 关于不向下修正药石转债转股价格的公告 | 2023-06-30 | Chinese | ||
| 40020442 | 关于公司高管辞职的公告 | 2023-06-30 | Chinese | ||
| 40020430 | 关于签订募集资金三方监管协议的公告 | 2023-06-30 | Chinese | ||
| 40020417 | 关于药石转债可能触发向下修正转股价格条件的提示性公告 | 2023-06-21 | Chinese | ||
| 40020412 | 2022年南京药石科技股份有限公司创业板向不特定对象发行可转换公司债券2023年跟踪评级报告 | 2023-06-20 | Chinese | ||
| 40020410 | 关于公司股东减持股份实施情况暨新减持计划的预披露公告 | 2023-06-15 | Chinese | ||
| 40020392 | 2022年环境、社会及公司治理(ESG)报告【英文版】 | 2023-06-15 | Chinese | ||
| 40019830 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司变更部分募集资金专户及新设募集资金专户的核查意见 | 2023-06-12 | Chinese | ||
| 40019822 | 独立董事关于第三届董事会第二十次会议相关事项的独立意见 | 2023-06-12 | Chinese | ||
| 40019802 | 关于使用银行承兑汇票支付募投项目资金的公告 | 2023-06-12 | Chinese | ||
| 40019789 | 关于变更部分募集资金专户及新设募集资金专户的公告 | 2023-06-12 | Chinese | ||
| 40019772 | 第三届董事会第二十次会议决议公告 | 2023-06-12 | Chinese | ||
| 40019758 | 华泰联合证券有限责任公司关于南京药石科技股份有限公司使用银行承兑汇票支付募投项目资金的核查意见 | 2023-06-12 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
PharmaBlock Sciences (Nanjing), Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55702/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55702 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55702 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55702 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55702}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PharmaBlock Sciences (Nanjing), Inc. (id: 55702)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.